ArticleJournal of pharmacokinetics and pharmacodynamics2015
Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies.
Eric L Haseltine et al.PubMed ↗Publisher ↗
No numbers read from the abstract.